Cognetivity Neurosciences Financials
| CGNSF Stock | USD 0 0 42.86% |
Cognetivity |
Understanding current and past Cognetivity Neurosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cognetivity Neurosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Cognetivity Neurosciences' assets may result in an increase in income on the income statement.
Cognetivity Neurosciences Stock Summary
Cognetivity Neurosciences competes with Cogstate, and EGF Theramed. Cognetivity Neurosciences Ltd. operates as a healthcare company. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Cognetivity Neurosciences operates under Health Information Services classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1055 West Hastings |
| Sector | Healthcare |
| Industry | Health Information Services |
| Benchmark | Dow Jones Industrial |
| Website | www.cognetivity.com |
| Phone | 604 688 9588 |
| Currency | USD - US Dollar |
Cognetivity Neurosciences Key Financial Ratios
There are many critical financial ratios that Cognetivity Neurosciences' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cognetivity Neurosciences reports annually and quarterly.| Return On Equity | -6.43 | |||
| Return On Asset | -2.04 | |||
| Beta | 0.13 | |||
| Z Score | -11.4 |
Cognetivity Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cognetivity Neurosciences's current stock value. Our valuation model uses many indicators to compare Cognetivity Neurosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cognetivity Neurosciences competition to find correlations between indicators driving Cognetivity Neurosciences's intrinsic value. More Info.Cognetivity Neurosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cognetivity Neurosciences' earnings, one of the primary drivers of an investment's value.Cognetivity Neurosciences Systematic Risk
Cognetivity Neurosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cognetivity Neurosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Cognetivity Neurosciences correlated with the market. If Beta is less than 0 Cognetivity Neurosciences generally moves in the opposite direction as compared to the market. If Cognetivity Neurosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cognetivity Neurosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cognetivity Neurosciences is generally in the same direction as the market. If Beta > 1 Cognetivity Neurosciences moves generally in the same direction as, but more than the movement of the benchmark.
Cognetivity Neurosciences December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cognetivity Neurosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cognetivity Neurosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cognetivity Neurosciences based on widely used predictive technical indicators. In general, we focus on analyzing Cognetivity Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cognetivity Neurosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 45.8 | |||
| Information Ratio | 0.148 | |||
| Maximum Drawdown | 192.86 | |||
| Value At Risk | (42.86) | |||
| Potential Upside | 100.0 |
Complementary Tools for Cognetivity Pink Sheet analysis
When running Cognetivity Neurosciences' price analysis, check to measure Cognetivity Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognetivity Neurosciences is operating at the current time. Most of Cognetivity Neurosciences' value examination focuses on studying past and present price action to predict the probability of Cognetivity Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognetivity Neurosciences' price. Additionally, you may evaluate how the addition of Cognetivity Neurosciences to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| CEOs Directory Screen CEOs from public companies around the world |